Navigation Links
Swiss Institute of Bioinformatics 10th Anniversary Conference
Date:9/12/2008

It is our pleasure to welcome you to the SIBs 10th Anniversary celebration. Many events are to take place throughout Switzerland. Amongst them, we are particularly happy to welcome you to our Anniversary Conference (see programme below) which will take place on Wednesday, 24th September at the Kultur-Casino, Herrengasse 25, Bern.

Pioneers at the heart of science

Wednesday, 24 September at the Kultur-Casino, Herrengasse 25, Bern, Switzerland

13.00-13.10
Welcome Address
Prof. Ron D. Appel, Director of the SIB

13.10-13.30
Introductory talk
The Systems Biology Era: integrating experimental sciences and bioinformatics to understand Biology
Prof. Manuel C. Peitsch, Chairman of the SIB Executive Board

13.30-13.50
Winner of the " SIB Young Bioinformatician Award 2008" talk

13.50-14.40
NCCR Frontier in Genetics talk
In vivo, in vitro, in silico: the future of biology, from genomes to synthetic cells
Prof. Antoine Danchin, Genetics of Bacterial Genomes Unit URA2171 CNRS, Director of the Genomes and Genetics Department, Institut Pasteur, Paris

14.4015-.10 Coffee break

15.10-15.00
Nobel Prize Winner talk
The impact of bioinformatics on our knowledge of life processes
Prof. Werner Arber, Professor emeritus for molecular microbiology, University of Basel, Nobel Laureate Physiology or Medicine 1978

16.00-16.50
Swiss Institute of Bioinformatics talk
Sequencing the invisible - environmental genomics as a new challenge for bioinformatics
Prof. Christian von Mering, SIB and Institute of Molecular Biology, University of Zurich

16.50-17.00 Closing Words


'/>"/>

Contact: SIB Secretariat
sib10@isb-sib.ch
41-216-924-050
Swiss Institute of Bioinoformatics
Source:Eurekalert

2

GOOD

Page: 1

Related biology news :

1. Syracuse University partners with Serum Institute of India to develop vaccines for children
2. Cornell gets $10 million NSF grant to establish new sustainability institute
3. Eli and Edythe L. Broad make unprecedented gift to endow Broad Institute of Harvard & MIT
4. NYU Cancer Institute researcher among first NIH EUREKA award recipients
5. Broad Institute awarded grant to develop chemical probes for human biology and disease
6. Broad Institute researchers introduce next generation tool for visualizing genomic data
7. Baker Institute report proposes strategies to ensure global energy security
8. New study spotlights National Institutes of Health grant outcomes for clinical research
9. UC San Diego launches Institute of Engineering in Medicine to accelerate health care tech
10. New round of Environmental Venture Projects from Stanfords Woods Institute
11. National Institutes of Health award Williams professor $217,710 research grant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)CORVALLIS, Ore. According to an analysis of statewide data taken from 1998-2001, women in Oregon who made less than $50,000 a year were more than three times likely to report they were discriminated
(Date:12/4/2009)Scientists from the Royal Botanic Gardens, Kew and the Natural History Museum believe that carnivorous behaviour in plants is far more widespread than previously thought, with many commonly grown plan
(Date:12/4/2009)This release is available in German . , A new study of the Max Planck Institute for Biology of Ageing could help to understand the positive effect of dietary restriction on healthy ageing. Previou
Breaking Biology News(10 mins):Lower income women report more insurance-based discrimination during pregnancy, delivery 2Scientists think 'killer petunias' should join the ranks of carnivorous plants 2How nutrition affects healthy aging 2Cynvec to Present at the 11th Annual Shanghai International Forum on Biotechnology and Pharmaceutical Industry 12429 1Cynvec to Present at the 11th Annual Shanghai International Forum on Biotechnology and Pharmaceutical Industry 12429 2Pharmasset to Present at Goldman Sachs and Needham Healthcare Conferences 4524 1Pharmasset to Present at Goldman Sachs and Needham Healthcare Conferences 4524 2Pharmasset to Present at Goldman Sachs and Needham Healthcare Conferences 4524 3Malaria Vaccine Developer Sanaria Inc Receives 2009 Vaccine Industry Excellence Award for Best Early Stage Vaccine Biotech 4522 1Malaria Vaccine Developer Sanaria Inc Receives 2009 Vaccine Industry Excellence Award for Best Early Stage Vaccine Biotech 4522 2
...ion, Matches with Watch-list Databases and Reports...ch 9 Neurotechnology, a provider of high-precisio...ounced the availability of VeriLook Surveillance S...identification using live video streams from high-...riLook 3.2 SDK and other facial recognition system...
...ch 12 (OTC Bulletin Board: CICI) Communication In... a leading supplier of electronic signature soluti...al industry* and the recognized leader** in biomet...ancial results for the fourth quarter and the year...the three months ended December 31, 2008 were $843...
...tion growth in southern Nevada has placed increasi...80% of the state,s residents lived in southern Nev...eople. The dual concerns of this population boom a... conditions has created an urgent demand for offic... meet resident and visitor demand., Las Vegas oper...
Other Biology News:VeriLook Surveillance SDK Provides Real-Time Face Identification Using Video Surveillance Cameras 2VeriLook Surveillance SDK Provides Real-Time Face Identification Using Video Surveillance Cameras 3Communication Intelligence Corporation Reports Fourth Quarter and Fiscal 2008 Results 2Communication Intelligence Corporation Reports Fourth Quarter and Fiscal 2008 Results 3Communication Intelligence Corporation Reports Fourth Quarter and Fiscal 2008 Results 4Communication Intelligence Corporation Reports Fourth Quarter and Fiscal 2008 Results 5Communication Intelligence Corporation Reports Fourth Quarter and Fiscal 2008 Results 6Keeping golf courses green when fresh water is limited 2Keeping golf courses green when fresh water is limited 3
(Date:12/3/2009)DALLAS, Dec. 3 ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP), today provided an update on its European commercial launch of MuGard, an FDA approved treatment for oral mucositis, a deb
(Date:12/3/2009)PHILADELPHIA, Dec. 3 Shire plc (LSE: SHP, Nasdaq: SHPGY ), the global specialty biopharmaceutical company, today announced a voluntary recall of five lots and voluntary market withdrawal of one lot
(Date:12/3/2009)WALTHAM, Mass., Dec. 3 Inverness Medical Innovations, Inc. (NYSE: IMA ), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and h
(Date:12/3/2009)NEW DELHI, India, Dec. 3 /PRNewswire-Asia/ -- Dr. Susan Jiang, M.D., Ph.D.,Chief Science Officer at Shenzhen Beike Biotechnology Co. Ltd.,( http://www.beikebiotech.com ), spoke at a conference on Hig
Breaking Biology Technology:Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 3Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 3Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 5Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 3
...within government channels, WEST PORT, Conn., and...c. (ABH) and Regenesis Biomedical, Inc. announced ...magraft(R) within the United,States (US) governmen...Regenesis will provide its specialized sales force...eran,s Administration (VA), Department of Defense,...
...ical,Services, Inc. (NYSE: WST ) today announced ...er 2008 cash dividend of $0.14 per share. The,divi...s of record on July,23, 2008., About West Pharmac...ces, Inc. is a global manufacturer of,components a... stoppers and,seals for vials, and closures and di...
...l/Mixed tropic HIV patients with ...May 7 Pathway Diagnostics announces,nationwide av...ular,SensiTrop(TM) II assay, combining the sensiti...) technology with the specificity of molecular,seq...atus of HIV infected,patients. Pathway performs th...
Other Biology Technology:Advanced BioHealing and Regenesis Biomedical Form Co-Promotion Alliance for Dermagraft(R) 2Advanced BioHealing and Regenesis Biomedical Form Co-Promotion Alliance for Dermagraft(R) 3Pathway Diagnostics Announces Commercial Availability of Second Generation SensiTrop(TM) II Molecular HIV Co-receptor Tropism Assay 2
Anti-Histone H2B, acetyl (Lys20) Antibody, Unconjugated from Cell Signaling Technology
Rhodamine-B-isothiocyanate from Research Organics, Inc.
Rabbit Anti-Human MMP-7, aminoterminal end active enzyme, Antibody, Unconjugated from CEDARLANE Laboratories Limited
Mouse Anti-CD42d Monoclonal Antibody, Unconjugated, Clone CLB-SW16 (formerly 708) from Abcam
Biology Products: